210 related articles for article (PubMed ID: 38417029)
41. An adherent mucus layer attenuates the genotoxic effect of colibactin.
Reuter C; Alzheimer M; Walles H; Oelschlaeger TA
Cell Microbiol; 2018 Feb; 20(2):. PubMed ID: 29156489
[TBL] [Abstract][Full Text] [Related]
42. Intracellular colon cancer-associated Escherichia coli promote protumoral activities of human macrophages by inducing sustained COX-2 expression.
Raisch J; Rolhion N; Dubois A; Darfeuille-Michaud A; Bringer MA
Lab Invest; 2015 Mar; 95(3):296-307. PubMed ID: 25545478
[TBL] [Abstract][Full Text] [Related]
43. Gut symbionts from distinct hosts exhibit genotoxic activity via divergent colibactin biosynthesis pathways.
Engel P; Vizcaino MI; Crawford JM
Appl Environ Microbiol; 2015 Feb; 81(4):1502-12. PubMed ID: 25527542
[TBL] [Abstract][Full Text] [Related]
44. Increased Epithelial Oxygenation Links Colitis to an Expansion of Tumorigenic Bacteria.
Cevallos SA; Lee JY; Tiffany CR; Byndloss AJ; Johnston L; Byndloss MX; Bäumler AJ
mBio; 2019 Oct; 10(5):. PubMed ID: 31575772
[TBL] [Abstract][Full Text] [Related]
45. Shining a Light on Colibactin Biology.
Dougherty MW; Jobin C
Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34065799
[TBL] [Abstract][Full Text] [Related]
46. Activity-Based Probe for Screening of High-Colibactin Producers from Clinical Samples.
Hirayama Y; Tsunematsu Y; Yoshikawa Y; Tamafune R; Matsuzaki N; Iwashita Y; Ohnishi I; Tanioka F; Sato M; Miyoshi N; Mutoh M; Ishikawa H; Sugimura H; Wakabayashi K; Watanabe K
Org Lett; 2019 Jun; 21(12):4490-4494. PubMed ID: 31192617
[TBL] [Abstract][Full Text] [Related]
47. [Microbiota and colorectal cancer: genotoxic bacteria in the intestinal tract].
Nougayrède JP; Oswald E
Bull Acad Natl Med; 2011 Jun; 195(6):1295-304; discussion 1304-5. PubMed ID: 22530520
[TBL] [Abstract][Full Text] [Related]
48. Induction of DNA Damage in Mouse Colorectum by Administration of Colibactin-producing
Narita T; Tsunematsu Y; Miyoshi N; Komiya M; Hamoya T; Fujii G; Yoshikawa Y; Sato M; Kawanishi M; Sugimura H; Iwashita Y; Totsuka Y; Terasaki M; Watanabe K; Wakabayashi K; Mutoh M
In Vivo; 2022; 36(2):628-634. PubMed ID: 35241515
[TBL] [Abstract][Full Text] [Related]
49. Colibactin: More Than a New Bacterial Toxin.
Faïs T; Delmas J; Barnich N; Bonnet R; Dalmasso G
Toxins (Basel); 2018 Apr; 10(4):. PubMed ID: 29642622
[TBL] [Abstract][Full Text] [Related]
50. Advancing the Biosynthetic and Chemical Understanding of the Carcinogenic Risk Factor Colibactin and Its Producers.
Hirayama Y; Sato M; Watanabe K
Biochemistry; 2022 Dec; 61(24):2782-2790. PubMed ID: 35723977
[TBL] [Abstract][Full Text] [Related]
51. A small molecule inhibitor prevents gut bacterial genotoxin production.
Volpe MR; Velilla JA; Daniel-Ivad M; Yao JJ; Stornetta A; Villalta PW; Huang HC; Bachovchin DA; Balbo S; Gaudet R; Balskus EP
Nat Chem Biol; 2023 Feb; 19(2):159-167. PubMed ID: 36253549
[TBL] [Abstract][Full Text] [Related]
52. Oral tolerance failure upon neonatal gut colonization with Escherichia coli producing the genotoxin colibactin.
Secher T; Payros D; Brehin C; Boury M; Watrin C; Gillet M; Bernard-Cadenat I; Menard S; Theodorou V; Saoudi A; Olier M; Oswald E
Infect Immun; 2015 Jun; 83(6):2420-9. PubMed ID: 25824839
[TBL] [Abstract][Full Text] [Related]
53. Isolation of New Colibactin Metabolites from Wild-Type
Zhou T; Hirayama Y; Tsunematsu Y; Suzuki N; Tanaka S; Uchiyama N; Goda Y; Yoshikawa Y; Iwashita Y; Sato M; Miyoshi N; Mutoh M; Ishikawa H; Sugimura H; Wakabayashi K; Watanabe K
J Am Chem Soc; 2021 Apr; 143(14):5526-5533. PubMed ID: 33787233
[TBL] [Abstract][Full Text] [Related]
54. Targeted depletion of
Blanco-Míguez A; Marcos-Fernández R; Guadamuro-García L; Fdez-Riverola F; Cubiella J; Lourenço A; Margolles A; Sánchez B
mSystems; 2023 Jun; 8(3):e0007923. PubMed ID: 37219498
[TBL] [Abstract][Full Text] [Related]
55. Medicinal plant extracts protect epithelial cells from infection and DNA damage caused by colibactin-producing Escherichia coli, and inhibit the growth of bacteria.
Kaewkod T; Tobe R; Tragoolpua Y; Mihara H
J Appl Microbiol; 2021 Mar; 130(3):769-785. PubMed ID: 32767847
[TBL] [Abstract][Full Text] [Related]
56. ClbS Is a Cyclopropane Hydrolase That Confers Colibactin Resistance.
Tripathi P; Shine EE; Healy AR; Kim CS; Herzon SB; Bruner SD; Crawford JM
J Am Chem Soc; 2017 Dec; 139(49):17719-17722. PubMed ID: 29112397
[TBL] [Abstract][Full Text] [Related]
57. Oxygen concentration modulates colibactin production.
Bossuet N; Guyonnet C; Chagneau CV; Tang-Fichaux M; Penary M; Loubet D; Branchu P; Oswald E; Nougayrede JP
Gut Microbes; 2023; 15(1):2222437. PubMed ID: 37312436
[TBL] [Abstract][Full Text] [Related]
58. Enrichment of colibactin-associated mutational signatures in unexplained colorectal polyposis patients.
Terlouw D; Boot A; Ducarmon QR; Nooij S; Suerink M; van Leerdam ME; van Egmond D; Tops CM; Zwittink RD; Ruano D; Langers AMJ; Nielsen M; van Wezel T; Morreau H
BMC Cancer; 2024 Jan; 24(1):104. PubMed ID: 38238650
[TBL] [Abstract][Full Text] [Related]
59. Tackling the Threat of Cancer Due to Pathobionts Producing Colibactin: Is Mesalamine the Magic Bullet?
Tang-Fichaux M; Branchu P; Nougayrède JP; Oswald E
Toxins (Basel); 2021 Dec; 13(12):. PubMed ID: 34941734
[TBL] [Abstract][Full Text] [Related]
60. Biosynthesis and bioactivities of microbial genotoxin colibactins.
Tang JW; Liu X; Ye W; Li ZR; Qian PY
Nat Prod Rep; 2022 May; 39(5):991-1014. PubMed ID: 35288725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
